Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.
Founding Scientist
Digital twins can prevent $2M failed batches and help pharma companies avoid $50–$200M revenue risks from regulatory issues. Read the full article to learn how digital twins provide solutions.
Head of Marketing (Dec 2014 – Present)
Pharma’s shift to data-driven commercialization is reshaping decisions amid rising compliance, pricing, and ESG pressures. While AI shows selective gains, ROI gaps persist, exposing value chain vulnerabilities and execution challenges in high-growth segments.
Regional Vice President (Dec 2024 – Present)
Structural shifts in healthcare revenue cycle management are reshaping tech adoption, while automation ROI, regulatory constraints, and operational complexity determine scalability, revealing underpenetrated opportunities across provider segments and administrative ecosystems.
Founder & Director at Zantus Lifesciences (Apr 2025 – Present); India
AI-driven, end-to-end integration across R&D, manufacturing, and supply chains is reshaping life sciences leadership. Decisive now due to margin pressure and regulatory complexity, returns hinge on execution, compliance trade-offs, and fragile global supply nodes.
Cell Therpay Expert with 20+ years of experience in the field.
This article talks about the hidden operational challenges in cell therapy manufacturing, from biological variability and validation limits to assay bottlenecks and the structural foundations required for sustainable commercial scale.
Regional GPP/GSCS Latam Manager (May 2015 – Present); Mexico
Discover how supply chain leaders are navigating rising costs, security risks, and regulatory challenges in Latin America's pharmaceutical industry. Read the full article for expert insights!